AMYLGEN

amylgen-logo

Amylgen is a contract research organization that helps in the development of new Nutraceuticals on proposing unique Vivo models.

#SimilarOrganizations #Website #More

AMYLGEN

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2009-01-01

Address:
Montferrier-sur-lez, Languedoc-Roussillon, France

Country:
France

Website Url:
http://www.amylgen.com

Total Employee:
1+

Status:
Active

Contact:
33 467639987

Email Addresses:
[email protected]

Technology used in webpage:
Domain Not Resolving


Similar Organizations

a-pharma-logo

A-Pharma

A-Pharma is a contract research organization that specializes in the research of drugs, medical devices and food supplements.

aurelia-bioscience-logo

Aurelia Bioscience

Aurelia Bioscience is a pre-clinical contract research organisation (CRO) specialising in bioassay development, pharmacological profiling.

not_available_image

ClinStar

ClinStar is a clinical research organization, provides clinical development services to pharmaceutical and biotechnology industries.

evvivax-logo

EVVIVAX

EVVIVAX is a biotechnology company that pursues the discovery and development of innovative Therapeutic Veterinary Cancer Vaccines.

vivo-science-gmbh-logo

vivo Science GmbH

vivo Science is a contract research organization based in Germany that performs studies on immunology and toxicology.

Official Site Inspections

http://www.amylgen.com

Unable to get host informations!!!

Loading ...

More informations about "Amylgen"

Amylgen Company Profile - Office Locations, Competitors ... - Craft

Amylgen is a contract research organization that offers in vivo models of ageing, psychiatric, and neurodegenerative pathologies for the development of new medicines or nutraceuticals. Its โ€ฆSee details»

Amylgen - LinkedIn

Amylgen is a CRO proposing innovative in vivo models of ageing, psychiatric and neurodegenerative pathologies for the development of new medicines or nutraceuticals. Amylgen is at your service to ...See details»

Amylgen 2025 Company Profile: Valuation, Funding & Investors

Amylgen General Information Description. Operator of a biotechnology company intended to offer preclinical CRO in vivo models of psychiatric and neurodegenerative diseases. The company โ€ฆSee details»

Amylgen - Crunchbase Company Profile & Funding

Amylgen is a contract research organization that helps in the development of new Nutraceuticals on proposing unique Vivo models. Montferrier-sur-lez, Languedoc-Roussillon, France; 1-10; โ€ฆSee details»

Amylgen SAS Company Profile, Financial and Strategic SWOT

Amylgen SAS operates as a contract research organization for the pharmaceutical industry. Its services include animal models of brain diseases, such as Alzheimer, Parkinson, โ€ฆSee details»

AMYLGEN Company Profile | CLERMONT L HERAULT ... - Dun

Find company research, competitor information, contact details & financial data for AMYLGEN of CLERMONT L HERAULT, OCCITANIE. Get the latest business insights from Dun & Bradstreet.See details»

AMYLGEN: Your partner for the discovery of new drug candidates

Amylgen โ€ขAmylgenwas created in 2009 as a spin off of the University of Montpellier โ€ขIn2014, Amylgenmoved to its own A1 certified housing animal facility โ€ขFacilities include an extensive โ€ฆSee details»

Amylgen - Drug pipelines, Patents, Clinical trials - Synapse

Explore Amylgen with its drug pipeline, therapeutic area, technology platform, .See details»

Amylgen SAS - CMOCRO - Domain Name

Amylgen SAS is a contract research organisation dedicated to in vivo models in the central nervous system (CNS) area. Amylgen provides a comprehensive platform of models and โ€ฆSee details»

Amylgen - VentureRadar

Mar 23, 2020 Curia Unknown n/a Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug โ€ฆSee details»

Amylgen Overview | SignalHire Company Profile

Amylgen is a contract research organization that helps in the development of new Nutraceuticals on proposing unique Vivo models. ... Amylgen is a CRO proposing innovative in vivo models of โ€ฆSee details»

Amylgen, your partner for brain health products development | 9932

Acting as a CRO, Amylgen has developed a unique and proprietary know-how on rodent models of Alzheimerâ??s disease and other CNS pathologies. We are work..9932 Walsh Medical โ€ฆSee details»

Amylgen - Overview, News & Competitors | ZoomInfo.com

Amylgen. Business Services · France · <25 Employees . Amylgen is a privately held preclinical CRO offering a unique combination of validated in-vivo rodent models and a full range testing โ€ฆSee details»

Amylgen - Crunchbase

Amylgen is a contract research organization that helps in the development of new Nutraceuticals on proposing unique Vivo models.See details»

Amylgen | Montferrier-sur-Lez - Facebook

Amylgen is a preclinical CRO offering in vivo models of psyhiatric... Amylgen, Montferrier-Sur-Lez, Languedoc-Roussillon, France. 72 likes · 7 were here. Amylgen is a preclinical CRO offering โ€ฆSee details»

AMYLGEN : Your partner for the discovery of new drug candidates

Amylgen โ€ข Amylgen was created in 2009 as a spin off of the University of Montpellier โ€ข In 2014, Amylgen moved to its own A1 certified housing animal facility โ€ข Facilities include an extensive โ€ฆSee details»

Top Amylgen Competitors and Alternatives | Craft.co

Amylgen's main competitors include Global Clinical Trials, 360biolabs, Excelya and CRS Clinical Research Services. Compare Amylgen to its competitors by revenue, employee growth and โ€ฆSee details»

Amylgen and Neuron-Experts Announce Strategic Partnership

Dec 11, 2019 Laura Ceolin - [email protected] www.amylgen.fr Tel: +33 4 67 63 99 87 Neuron-Experts [email protected] www.neuronexperts.com Tel: +33 4 86 01 11 95 โ€ฆSee details»

Amylgen - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Amylgen is a contract research organization that helps in the development of new Nutraceuticals on proposing unique Vivo models. New. Resources. Advanced Search. Start Free Trial . ...See details»

Amylgen and Neuron-Experts Announce Strategic Partnership

Dec 11, 2019 Amylgen will market this joint offering, that will be launched as a first step to assess the efficacy of compounds on Alzheimerโ€™s Disease. The offer will be rapidly extended โ€ฆSee details»

linkstock.net © 2022. All rights reserved